Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 12, 2011Current Medical Research and Opinion

Tolerability and efficacy of memantine add-on therapy to rivastigmine transdermal patches in mild to moderate Alzheimer's disease: a multicenter, randomized, open-label, parallel-group study

View Full Paper
Ask AI
Bookmark
Share

Authors

SCSeong Hye ChoiInha UniversityKPKyung Won ParkDementia UKDNDuk L. NaSamsung Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Choi et al. (2011) studied this question.

synapsesocial.com/papers/6a0043ceb124fe581985d00ehttps://doi.org/10.1185/03007995.2011.582484
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A review comparing the safety and tolerability of memantine with the acetylcholinesterase inhibitors2010 · 75 citations
  2. 2Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment2005 · 105 citations
  3. 3Memantine Therapy for Alzheimer Disease in Real-world Practice2008 · 34 citations
  4. 4Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment2006 · 223 citations
  5. 5Safety and Tolerability of Donepezil, Rivastigmine and Galantamine for Patients with Alzheimer’s Disease: Systematic Review of the ‘Real-World’ Evidence2009 · 107 citations